Olema Pharmaceuticals Statistics Share Statistics Olema Pharmaceuticals has 68.63M
shares outstanding. The number of shares has increased by 19.79%
in one year.
Shares Outstanding 68.63M Shares Change (YoY) 19.79% Shares Change (QoQ) 0.31% Owned by Institutions (%) 77.76% Shares Floating 52.86M Failed to Deliver (FTD) Shares 612 FTD / Avg. Volume 0.07%
Short Selling Information The latest short interest is 8.24M, so 12% of the outstanding
shares have been sold short.
Short Interest 8.24M Short % of Shares Out 12% Short % of Float 13.21% Short Ratio (days to cover) 4.7
Valuation Ratios The PE ratio is -2.65 and the forward
PE ratio is -5.21.
Olema Pharmaceuticals's PEG ratio is
-0.94.
PE Ratio -2.65 Forward PE -5.21 PS Ratio 0 Forward PS 203.2 PB Ratio 0.84 P/FCF Ratio -3.28 PEG Ratio -0.94
Financial Ratio History Enterprise Valuation Currently the Enterprise Value (EV) is not available for Olema Pharmaceuticals.
EV / Sales n/a EV / EBITDA n/a EV / EBIT n/a EV / FCF n/a
Financial Position The company has a current ratio of 10.5,
with a Debt / Equity ratio of 0.
Current Ratio 10.5 Quick Ratio 10.5 Debt / Equity 0 Debt / EBITDA -0.01 Debt / FCF -0.01 Interest Coverage 0
Financial Efficiency Return on Equity is n/a and Return on Invested Capital is n/a.
Return on Equity n/a Return on Assets n/a Return on Invested Capital n/a Revenue Per Employee n/a Profits Per Employee $-1.35M Employee Count 96 Asset Turnover 0 Inventory Turnover n/a
Taxes Income Tax n/a Effective Tax Rate 0%
Stock Price Statistics The stock price has increased by -4.31% in the
last 52 weeks. The beta is 2.09, so Olema Pharmaceuticals's
price volatility has been higher than the market average.
Beta 2.09 52-Week Price Change -4.31% 50-Day Moving Average 6.79 200-Day Moving Average 5.31 Relative Strength Index (RSI) 77.8 Average Volume (20 Days) 820,004
Income Statement
Revenue n/a Gross Profit -393K Operating Income -142.26M Net Income -129.47M EBITDA -129.08M EBIT -129.47M Earnings Per Share (EPS) -2.2
Full Income Statement Balance Sheet The company has 139.48M in cash and 1.43M in
debt, giving a net cash position of 138.05M.
Cash & Cash Equivalents 139.48M Total Debt 1.43M Net Cash 138.05M Retained Earnings -435.11M Total Assets 382M Working Capital 334.56M
Full Balance Sheet Cash Flow In the last 12 months, operating cash flow was -104.35M
and capital expenditures -159K, giving a free cash flow of -104.51M.
Operating Cash Flow -104.35M Capital Expenditures -159K Free Cash Flow -104.51M FCF Per Share -1.78
Full Cash Flow Statement Margins
Gross Margin n/a Operating Margin n/a Pretax Margin n/a Profit Margin n/a EBITDA Margin n/a EBIT Margin n/a FCF Margin n/a
